The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Anti-Infective Products Market Research Report 2025
Synopsis
Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
The global OTC Anti-Infective Products market was valued at US$ 13320 million in 2023 and is anticipated to reach US$ 16880 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Products.
Report Scope
The OTC Anti-Infective Products market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Anti-Infective Products market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sales Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Anti-Infective Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
The global OTC Anti-Infective Products market was valued at US$ 13320 million in 2023 and is anticipated to reach US$ 16880 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Products.
Report Scope
The OTC Anti-Infective Products market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Anti-Infective Products market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sales Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Anti-Infective Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OTC Anti-Infective Products Market Overview
1.1 Product Overview and Scope of OTC Anti-Infective Products
1.2 OTC Anti-Infective Products Segment by Type
1.2.1 Global OTC Anti-Infective Products Market Value Comparison by Type (2024-2030)
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 OTC Anti-Infective Products Segment by Sales Channel
1.3.1 Global OTC Anti-Infective Products Market Value by Sales Channel: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
1.4.1 Global OTC Anti-Infective Products Revenue 2019-2030
1.4.2 Global OTC Anti-Infective Products Sales 2019-2030
1.4.3 Global OTC Anti-Infective Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Anti-Infective Products Market Competition by Manufacturers
2.1 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OTC Anti-Infective Products Average Price by Manufacturers (2019-2024)
2.4 Global OTC Anti-Infective Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Anti-Infective Products, Product Type & Application
2.7 OTC Anti-Infective Products Market Competitive Situation and Trends
2.7.1 OTC Anti-Infective Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Anti-Infective Products Players Market Share by Revenue
2.7.3 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Anti-Infective Products Retrospective Market Scenario by Region
3.1 Global OTC Anti-Infective Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Anti-Infective Products Global OTC Anti-Infective Products Sales by Region: 2019-2030
3.2.1 Global OTC Anti-Infective Products Sales by Region: 2019-2024
3.2.2 Global OTC Anti-Infective Products Sales by Region: 2025-2030
3.3 Global OTC Anti-Infective Products Global OTC Anti-Infective Products Revenue by Region: 2019-2030
3.3.1 Global OTC Anti-Infective Products Revenue by Region: 2019-2024
3.3.2 Global OTC Anti-Infective Products Revenue by Region: 2025-2030
3.4 North America OTC Anti-Infective Products Market Facts & Figures by Country
3.4.1 North America OTC Anti-Infective Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Anti-Infective Products Sales by Country (2019-2030)
3.4.3 North America OTC Anti-Infective Products Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Anti-Infective Products Market Facts & Figures by Country
3.5.1 Europe OTC Anti-Infective Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Anti-Infective Products Sales by Country (2019-2030)
3.5.3 Europe OTC Anti-Infective Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Anti-Infective Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Anti-Infective Products Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Anti-Infective Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
3.7.1 Latin America OTC Anti-Infective Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Anti-Infective Products Sales by Country (2019-2030)
3.7.3 Latin America OTC Anti-Infective Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Anti-Infective Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Anti-Infective Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Anti-Infective Products Sales by Type (2019-2030)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2019-2024)
4.1.2 Global OTC Anti-Infective Products Sales by Type (2025-2030)
4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2019-2030)
4.2 Global OTC Anti-Infective Products Revenue by Type (2019-2030)
4.2.1 Global OTC Anti-Infective Products Revenue by Type (2019-2024)
4.2.2 Global OTC Anti-Infective Products Revenue by Type (2025-2030)
4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2019-2030)
4.3 Global OTC Anti-Infective Products Price by Type (2019-2030)
5 Segment by Sales Channel
5.1 Global OTC Anti-Infective Products Sales by Sales Channel (2019-2030)
5.1.1 Global OTC Anti-Infective Products Sales by Sales Channel (2019-2024)
5.1.2 Global OTC Anti-Infective Products Sales by Sales Channel (2025-2030)
5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2019-2030)
5.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2019-2030)
5.2.1 Global OTC Anti-Infective Products Revenue by Sales Channel (2019-2024)
5.2.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2025-2030)
5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2019-2030)
5.3 Global OTC Anti-Infective Products Price by Sales Channel (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer OTC Anti-Infective Products Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK OTC Anti-Infective Products Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva OTC Anti-Infective Products Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 NOVARTIS
6.5.1 NOVARTIS Corporation Information
6.5.2 NOVARTIS Description and Business Overview
6.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
6.5.5 NOVARTIS Recent Developments/Updates
6.6 MYLAN
6.6.1 MYLAN Corporation Information
6.6.2 MYLAN Description and Business Overview
6.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MYLAN OTC Anti-Infective Products Product Portfolio
6.6.5 MYLAN Recent Developments/Updates
6.7 Sun Pharma
6.6.1 Sun Pharma Corporation Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
6.7.5 Sun Pharma Recent Developments/Updates
6.8 CR SANJIU
6.8.1 CR SANJIU Corporation Information
6.8.2 CR SANJIU Description and Business Overview
6.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
6.8.5 CR SANJIU Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla OTC Anti-Infective Products Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Lingrui
6.10.1 Lingrui Corporation Information
6.10.2 Lingrui Description and Business Overview
6.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lingrui OTC Anti-Infective Products Product Portfolio
6.10.5 Lingrui Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Anti-Infective Products Industry Chain Analysis
7.2 OTC Anti-Infective Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Anti-Infective Products Production Mode & Process
7.4 OTC Anti-Infective Products Sales and Marketing
7.4.1 OTC Anti-Infective Products Sales Channels
7.4.2 OTC Anti-Infective Products Distributors
7.5 OTC Anti-Infective Products Customers
8 OTC Anti-Infective Products Market Dynamics
8.1 OTC Anti-Infective Products Industry Trends
8.2 OTC Anti-Infective Products Market Drivers
8.3 OTC Anti-Infective Products Market Challenges
8.4 OTC Anti-Infective Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Anti-Infective Products Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OTC Anti-Infective Products Market Value Comparison by Sales Channel (2024-2030) & (US$ Million)
Table 3. Global OTC Anti-Infective Products Market Competitive Situation by Manufacturers in 2023
Table 4. Global OTC Anti-Infective Products Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OTC Anti-Infective Products Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OTC Anti-Infective Products Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OTC Anti-Infective Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Anti-Infective Products, Product Type & Application
Table 12. Global Key Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OTC Anti-Infective Products Sales by Region (2019-2024) & (M Units)
Table 18. Global OTC Anti-Infective Products Sales Market Share by Region (2019-2024)
Table 19. Global OTC Anti-Infective Products Sales by Region (2025-2030) & (M Units)
Table 20. Global OTC Anti-Infective Products Sales Market Share by Region (2025-2030)
Table 21. Global OTC Anti-Infective Products Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OTC Anti-Infective Products Revenue Market Share by Region (2019-2024)
Table 23. Global OTC Anti-Infective Products Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OTC Anti-Infective Products Revenue Market Share by Region (2025-2030)
Table 25. North America OTC Anti-Infective Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OTC Anti-Infective Products Sales by Country (2019-2024) & (M Units)
Table 27. North America OTC Anti-Infective Products Sales by Country (2025-2030) & (M Units)
Table 28. North America OTC Anti-Infective Products Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OTC Anti-Infective Products Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OTC Anti-Infective Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OTC Anti-Infective Products Sales by Country (2019-2024) & (M Units)
Table 32. Europe OTC Anti-Infective Products Sales by Country (2025-2030) & (M Units)
Table 33. Europe OTC Anti-Infective Products Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OTC Anti-Infective Products Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OTC Anti-Infective Products Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OTC Anti-Infective Products Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific OTC Anti-Infective Products Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific OTC Anti-Infective Products Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OTC Anti-Infective Products Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Anti-Infective Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OTC Anti-Infective Products Sales by Country (2019-2024) & (M Units)
Table 42. Latin America OTC Anti-Infective Products Sales by Country (2025-2030) & (M Units)
Table 43. Latin America OTC Anti-Infective Products Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OTC Anti-Infective Products Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OTC Anti-Infective Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OTC Anti-Infective Products Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa OTC Anti-Infective Products Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa OTC Anti-Infective Products Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Anti-Infective Products Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OTC Anti-Infective Products Sales (M Units) by Type (2019-2024)
Table 51. Global OTC Anti-Infective Products Sales (M Units) by Type (2025-2030)
Table 52. Global OTC Anti-Infective Products Sales Market Share by Type (2019-2024)
Table 53. Global OTC Anti-Infective Products Sales Market Share by Type (2025-2030)
Table 54. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OTC Anti-Infective Products Revenue Market Share by Type (2019-2024)
Table 57. Global OTC Anti-Infective Products Revenue Market Share by Type (2025-2030)
Table 58. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2019-2024)
Table 59. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2025-2030)
Table 60. Global OTC Anti-Infective Products Sales (M Units) by Sales Channel (2019-2024)
Table 61. Global OTC Anti-Infective Products Sales (M Units) by Sales Channel (2025-2030)
Table 62. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2019-2024)
Table 63. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2025-2030)
Table 64. Global OTC Anti-Infective Products Revenue (US$ Million) by Sales Channel (2019-2024)
Table 65. Global OTC Anti-Infective Products Revenue (US$ Million) by Sales Channel (2025-2030)
Table 66. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2019-2024)
Table 67. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2025-2030)
Table 68. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2019-2024)
Table 69. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer OTC Anti-Infective Products Product
Table 74. Bayer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GSK OTC Anti-Infective Products Product
Table 79. GSK Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva OTC Anti-Infective Products Product
Table 84. Teva Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson OTC Anti-Infective Products Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. NOVARTIS Corporation Information
Table 91. NOVARTIS Description and Business Overview
Table 92. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. NOVARTIS OTC Anti-Infective Products Product
Table 94. NOVARTIS Recent Developments/Updates
Table 95. MYLAN Corporation Information
Table 96. MYLAN Description and Business Overview
Table 97. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. MYLAN OTC Anti-Infective Products Product
Table 99. MYLAN Recent Developments/Updates
Table 100. Sun Pharma Corporation Information
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sun Pharma OTC Anti-Infective Products Product
Table 104. Sun Pharma Recent Developments/Updates
Table 105. CR SANJIU Corporation Information
Table 106. CR SANJIU Description and Business Overview
Table 107. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CR SANJIU OTC Anti-Infective Products Product
Table 109. CR SANJIU Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Cipla OTC Anti-Infective Products Product
Table 114. Cipla Recent Developments/Updates
Table 115. Lingrui Corporation Information
Table 116. Lingrui Description and Business Overview
Table 117. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Lingrui OTC Anti-Infective Products Product
Table 119. Lingrui Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. OTC Anti-Infective Products Distributors List
Table 123. OTC Anti-Infective Products Customers List
Table 124. OTC Anti-Infective Products Market Trends
Table 125. OTC Anti-Infective Products Market Drivers
Table 126. OTC Anti-Infective Products Market Challenges
Table 127. OTC Anti-Infective Products Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Anti-Infective Products
Figure 2. Global OTC Anti-Infective Products Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OTC Anti-Infective Products Market Share by Type in 2023 & 2030
Figure 4. Antifungal Product Picture
Figure 5. Antibacterial Product Picture
Figure 6. Antiviral Product Picture
Figure 7. Antiseptics Product Picture
Figure 8. Others Product Picture
Figure 9. Global OTC Anti-Infective Products Market Value Comparison by Sales Channel (2024-2030) & (US$ Million)
Figure 10. Global OTC Anti-Infective Products Market Share by Sales Channel in 2023 & 2030
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global OTC Anti-Infective Products Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global OTC Anti-Infective Products Market Size (2019-2030) & (US$ Million)
Figure 16. Global OTC Anti-Infective Products Sales (2019-2030) & (M Units)
Figure 17. Global OTC Anti-Infective Products Average Price (US$/Unit) & (2019-2030)
Figure 18. OTC Anti-Infective Products Report Years Considered
Figure 19. OTC Anti-Infective Products Sales Share by Manufacturers in 2023
Figure 20. Global OTC Anti-Infective Products Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest OTC Anti-Infective Products Players: Market Share by Revenue in 2023
Figure 22. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America OTC Anti-Infective Products Sales Market Share by Country (2019-2030)
Figure 25. North America OTC Anti-Infective Products Revenue Market Share by Country (2019-2030)
Figure 26. United States OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe OTC Anti-Infective Products Sales Market Share by Country (2019-2030)
Figure 29. Europe OTC Anti-Infective Products Revenue Market Share by Country (2019-2030)
Figure 30. Germany OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2019-2030)
Figure 37. China OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America OTC Anti-Infective Products Sales Market Share by Country (2019-2030)
Figure 47. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2019-2030)
Figure 48. Mexico OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country (2019-2030)
Figure 53. Turkey OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE OTC Anti-Infective Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of OTC Anti-Infective Products by Type (2019-2030)
Figure 57. Global Revenue Market Share of OTC Anti-Infective Products by Type (2019-2030)
Figure 58. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of OTC Anti-Infective Products by Sales Channel (2019-2030)
Figure 60. Global Revenue Market Share of OTC Anti-Infective Products by Sales Channel (2019-2030)
Figure 61. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2019-2030)
Figure 62. OTC Anti-Infective Products Value Chain
Figure 63. OTC Anti-Infective Products Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
